Drug Patent Expirations for the Week of April 23, 2023

CLINDESSE (clindamycin phosphate) Padagis us Patent: 6,899,890 Expiration: Apr 27, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]
The post Dr…


New patent expiration for Merck Sharp drug DUTREBIS

Annual Drug Patent Expirations for DUTREBIS Dutrebis is a drug marketed by Merck Sharp Dohme and is included in one NDA. There are five patents protecting this drug. This drug…
The post New patent expiration for Merck Sharp drug DUTREBIS appeared first…


Biotechblog